Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While MGF is upregulated in muscle after mechanical overload, where it supports tissue repair and growth; recombinant forms are studied for regenerative and performance-enhancement effects22138, Tesamorelin is FDA-approved to reduce excess visceral adipose tissue in HIV-associated lipodystrophy and is studied for broader body-composition, NAFLD, and cognitive effects via GH/IGF-1 axis modulation1893.
While MGF works as a 24-amino-acid E-peptide splice variant of IGF-1 (IGF-1Ec) produced in mechanically stressed or damaged muscle that activates IGF1R and local anabolic pathways involved in muscle repair and hypertrophy22138144, Tesamorelin is a full-length 44-amino-acid GHRH analog with an N-terminal trans-3-hexenoic acid modification that binds GHRHR, activating cAMP/PKA signaling to increase endogenous GH and IGF-1, with improved stability versus native GHRH182893102.
MGF
IGF1
Tesamorelin
GHRH
MGF and Tesamorelin are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: MGF is more often discussed in the realm of Musculoskeletal health, whereas Tesamorelin is more often associated with the realm of Metabolic and endocrine and Cardiovascular health. Their biological logic is quite different: MGF is a growth factor mimetic and a signaling modulator, whereas Tesamorelin is a receptor agonist. MGF has a more natural endogenous origin, while Tesamorelin is closer to synthetic analog background and their development context also differs, with MGF in Preclinical development while Tesamorelin is approved. MGF takes the form of a linear peptide, whereas Tesamorelin is closer to a peptide conjugate, Tesamorelin incorporates amidation features that are not part of MGF; while their sequence patterns also diverge, with MGF showing protein-mimetic sequence features and Tesamorelin showing alpha-helical domain features.
No related articles are linked to these peptides yet.